2000 September

Sino Biopharmaceutical Limited was listed on the Growth Enterprise Market (GEM) of The Stock Exchange of Hong Kong Limited (Stock Code: 0827)

2003 December

Sino Biopharmaceutical Ltd was successfully moved to the Main Board of The Stock Exchange of Hong Kong Limited (Stock Code: 1177)

2005 July

Sino Biopharmaceutical Ltd Sold one of the Group’s subsidiaries Shandong Chia Tai Freda Pharmaceutical Co., Ltd to Bausch & Lomb for US$200 Million

2011 December

The Company entered into the medical healthcare business by founding Chia Tai Shaoyang Orthopedic Hospital

2013 June

Sino Biopharmaceutical Limited entered the health food market by holding Tianjin Zhenwutang Food Co., Ltd.

2014 November

Sino Biopharmaceutical Limited made its presence in Europe by investing a stake in Karolinska Development AB

2017 December

Sino Biopharmaceutical Limited's market capital (Stock Code: 1177) surpassed HK$100 Billion.

2018 August

Sino Biopharmaceutical Limited was selected as a constituent stock of the Hang 

Seng Index.